Emma Davies

1.4k citations
23 papers · 275 indexed · h-index 8
Topics
SARS-CoV-2 and COVID-19 Research (6 papers)Virus-based gene therapy research (5 papers)Respiratory viral infections research (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEBMJ

In The Last Decade

Emma Davies

20 papers receiving 260 citations

Peers

Emma Davies
Comparison fields: 5 of 77
  • Infectious Diseases 183
  • Epidemiology 67
  • Genetics 52
  • Molecular Biology 37
  • Clinical Biochemistry 35
Replace John R. Vernaleo with:
John R. Vernaleo United States
Hidetoshi Nomoto Japan
Ben Warne United Kingdom
Camilla Holten Møller Denmark
Dhritiman V. Mukherjee United States
Christopher da Costa United States
Muna Al Maslamani Qatar
Elio Issa Lebanon
Nicole Barp Italy
Giorgio Tiecco Italy
Emma Davies relative to John R. Vernaleo United States John R. Vernaleo's profile →
Citations per field
00.5×3.9×
John R. Vernaleo · 1×
Citations per year

Countries citing papers authored by Emma Davies

Since Specialization
Citations

This map shows the geographic impact of Emma Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Davies more than expected).

Fields of papers citing papers by Emma Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Davies. The network helps show where Emma Davies may publish in the future.

Co-authorship network of co-authors of Emma Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Davies. A scholar is included among the top collaborators of Emma Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Davies. Emma Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 1
5 1
6 5
7 3
8 4
9 21
10 8
11 4
12 6
13 3
14 14
15 5
16 18
17 63
18 31
19 4
20 65

About Emma Davies

Emma Davies is a scholar working on Infectious Diseases, Epidemiology and Virology, having authored 23 papers that have together received 275 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (5 papers) and Respiratory viral infections research (5 papers). The work is most often cited by research in Infectious Diseases (183 citations), Clinical Biochemistry (35 citations) and Applied Microbiology and Biotechnology (6 citations). Emma Davies has collaborated with scholars based in United Kingdom, United States and United Arab Emirates. Frequent co-authors include A.M. Emmerson, G. Hogg, Margaret F. Patterson, M. D. Shields, Malcolm Guiver, Andrew Turner, Robert Wynn, Denise Bonney, John Read and Su Han Lum. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMJ.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026